Heath-Chiozzi Margo's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Jun 5, 2024
- Accession no.
- 0001415889-24-015544
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.96M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heath-Chiozzi MargoCIK 0001718112 | Officer (SVP OF REGULATORY AFFAIRS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | MOption exerciseAcquired | +6,289 | $9.02 | +$56,726.78 | 13,383 | Direct | |
| Jun 3, 2024 | Common Stock | MOption exerciseAcquired | +58,369 | $10.38 | +$605,870.22 | 71,752 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −58,369 | $33.65 | −$1,964,116.85 | 13,383 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | MOption exerciseDisposed | −6,289 | $0.00 | $0 | 0 | Direct | |
| Jun 3, 2024 | Common Stock | MOption exerciseDisposed | −58,369 | $0.00 | $0 | 23,023 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.